Ultragenyx Pharmaceutical (NASDAQ:RARE): Q1 GAAP EPS of -$2.05 misses by $0.37.
Revenue of $36.31M (+99.8% Y/Y) misses by $0.43M.
https://seekingalpha.com/news/3570401-ultragenyx-pharmaceutical-eps-misses-0_37-misses-on-revenueWednesday, May 6, 2020
Sarepta Therapeutics EPS misses by $1.75, misses on revenue
Sarepta Therapeutics (NASDAQ:SRPT): Q1 Non-GAAP EPS of -$1.04 misses by $1.75; GAAP EPS of -$0.23 misses by $0.67.
Revenue of $100.4M (+15.4% Y/Y) misses by $17.78M.
https://seekingalpha.com/news/3570415-sarepta-therapeutics-eps-misses-1_75-misses-on-revenueNuVasive EPS beats by $0.08, misses on revenue
Revenue of $259.88M (-5.4% Y/Y) misses by $2.03M.
https://seekingalpha.com/news/3570425-nuvasive-eps-beats-0_08-misses-on-revenueNeurocrine Biosciences EPS beats by $0.23, beats on revenue
Neurocrine Biosciences (NASDAQ:NBIX): Q1 Non-GAAP EPS of $0.82 beats by $0.23; GAAP EPS of $0.39 misses by $0.15.
Revenue of $237.1M (+71.3% Y/Y) beats by $10.81M.
https://seekingalpha.com/news/3570427-neurocrine-biosciences-eps-beats-0_23-beats-on-revenueLivongo Health EPS beats by $0.07, beats on revenue
Livongo Health (NASDAQ:LVGO): Q1 Non-GAAP EPS of $0.03 beats by $0.07; GAAP EPS of -$0.06 beats by $0.05.
Revenue of $68.82M (+114.6% Y/Y) beats by $2.71M.
Shares -0.98%.
https://seekingalpha.com/news/3570433-livongo-health-eps-beats-0_07-beats-on-revenueIronwood Pharmaceuticals EPS misses by $0.01, beats on revenue
Ironwood Pharmaceuticals (NASDAQ:IRWD): Q1 Non-GAAP EPS of $0.04 misses by $0.01; GAAP EPS of $0.02 misses by $0.01.
Revenue of $79.94M (+16.3% Y/Y) beats by $1.32M.
https://seekingalpha.com/news/3570459-ironwood-pharmaceuticals-eps-misses-0_01-beats-on-revenueOraSure Technologies EPS misses by $0.06, beats on revenue
OraSure Technologies (NASDAQ:OSUR): Q1 GAAP EPS of -$0.12 misses by $0.06.
Revenue of $31.6M (+4.9% Y/Y) beats by $2.12M.
Shares -0.06%.
https://seekingalpha.com/news/3570486-orasure-technologies-eps-misses-0_06-beats-on-revenue
Subscribe to:
Posts (Atom)